Wednesday, Feb 21, 2024 · SEC filings
What the smart money revealed on Feb 21
1,558 insider filings came in. We hid 89 planned (10b5-1) sellers and 1,235 people whose filings were routine, like grants and tax withholding.
Opko Health (OPK) CEO and Chairman Frost Phillip Md Et Al bought $990K
1M shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 9 checked quarters beat the typical stock 6 months later.
Herbalife (HLF) Chairman and CEO Michael Johnson bought $498K
61,725 shares on the open market. Not a grant or an option exercise.
Blackstone (BX) Director Reginald Brown bought $302K
2,400 shares on the open market. Not a grant or an option exercise.
Humana (HUM) Director Jorge Mesquita bought $200K
545 shares on the open market. Not a grant or an option exercise.
Medpace (MEDP) CEO August Troendle sold $25M
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 5.53M shares.
Reliance (RS) President Karla Lewis sold $13.7M
Not marked as a planned 10b5-1 sale. Sold 20% of the shares they held directly. Still holds 168,418 shares.
Teva Pharmaceutical Industries (TEVA) Executive VP Global Operations Eric Drape sold $2.26M
Not marked as a planned 10b5-1 sale. Sold 100% of the shares they held directly. Still holds 1 shares.
Show 31 more real buys
Show 156 more real sales
13F season
Holdings as of Dec 31, 2023 were due Feb 14
49 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Feb 15–21
Open-market buys by officers and directors, filed in the 7 days up to Feb 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.